Editorial

You have full text access to this OnlineOpen article

Revisiting the cytopathic effect of hepatitis B virus infection

  1. Volker Bruss Ph.D.*

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360605

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1327–1329, December 2002

Additional Information

How to Cite

Bruss, V. (2002), Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology, 36: 1327–1329. doi: 10.1002/hep.1840360605

Author Information

  1. Department of Virology, University of Göttingen, Germany

*Department of Virology, University of Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany. fax: (49) 551–394471

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (293K)

Reference

  • 1
    Hollinger FB, Liang TJ. Hepatitis B virus. In: KnipeDM, HowleyPM, ChanockRM, MonathTP, RoizmanB, StrausSE, eds. Fields Virology. Philadelphia: Lippincott-Raven, 2000: 2971–3036.
  • 2
    Chisari FV. Hepatitis B virus immunopathogenesis. Ann Rev Immuno 1995; 13: 29–60.
  • 3
    Bartholomeusz A, Locarnini S. Hepatitis B virus mutants and fulminant hepatitis B: fitness plus phenotype. Hepatology 2001; 34: 432–435.
    Direct Link:
  • 4
    Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A 1987; 84: 6909–6913.
  • 5
    Heermann KH, Goldmann U, Schartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface protein of hepatitis B virus containing the pre-s sequence. J Virol 1984; 52: 396–402.
  • 6
    Ganem D, Schneider RJ. Hepadnaviridae and their replication. In: KnipeDM, HowleyPM, ChanockRM, MonathTP, RoizmanB, StrausSE, eds. Fields Virology. Philadelphia: Lippincott-Raven, 2000: 2923–2970.
  • 7
    Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991; 88: 1059–1063.
  • 8
    Bruss V. A short linear sequence of the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol 1997; 71: 9350–9357.
  • 9
    Bruss V, Gerhardt E, Vieluf K, Wunderlich G. Functions of the large hepatitis B virus surface protein in viral particle morphogenesis. Intervirol 1996; 39: 23–31.
  • 10
    Cheng KC, Smith GL, Moss B. Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol 1986; 60: 337–344.
  • 11
    Persing DH, Varmus HE, Ganem D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 1986; 234: 1388–1391.
  • 12
    Standring DN, Ou JH, Rutter WJ. Assembly of viral particles in Xenopus oocytes: pre-surface-antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci U S A 1986; 83: 9338–9342.
  • 13
    McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorge J, Chisari FV. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol 1987; 61: 683–692.
  • 14
    Xu Z, Bruss V, Yen TSB. Formation of intracellular particles by hepatitis B virus large surface protein. J Virol 1997; 71: 5487–5494.
  • 15
    Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145–1156.
  • 16
    Foo N, Ahn BY, Ma X, Hyun W, Yen TSB. Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology 2002; 36: 1400–1407.
  • 17
    Mason AL, Wick M, White HM, Benner KG, Lee RG, Regenstein F, Riely CA, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237–244.
  • 18
    Fans, JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B. Lancet 1993; 342: 1175.
  • 19
    Fang JWS, Tung FYT, Davis GL, Dolson DJ, van Theil DH, Lau JYN. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901–904.
  • 20
    Hung YB, Liang JT, Chu JS, Chen KM, Lee CS. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigen: a case report of fibrosing cholestatic hepatitis. Hepatogastroenterol 1995; 42: 913–918.
  • 21
    Xu Z, Jensen G, Yen TSB. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 1997; 71: 7387–7392.
  • 22
    Hildt E, Saher G, Bruss V, Hofschneider PH. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 1996; 225: 235–239.
  • 23
    Yen TSB. Regulation of hepatitis B virus gene expression. Semin Virol 1993; 4: 33–42.
  • 24
    Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65–91.
  • 25
    Bruss V, Thomssen R. Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol 1994; 68: 1643–1650.
Get PDF (293K)